These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22956446)

  • 1. Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia.
    Jena AB; Sun E; Goldman DP
    J Gen Intern Med; 2013 Feb; 28(2):223-30. PubMed ID: 22956446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
    Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
    Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
    Giuliano C; Wilhelm SM; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.
    Othman F; Crooks CJ; Card TR
    BMJ; 2016 Nov; 355():i5813. PubMed ID: 28715344
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
    Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
    Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population.
    Cohen SM; Lee HJ; Leiman DA; Roy N; Misono S
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):519-525. PubMed ID: 30419774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.
    Lambert AA; Lam JO; Paik JJ; Ugarte-Gil C; Drummond MB; Crowell TA
    PLoS One; 2015; 10(6):e0128004. PubMed ID: 26042842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults.
    Zirk-Sadowski J; Masoli JA; Delgado J; Hamilton W; Strain WD; Henley W; Melzer D; Ble A
    J Am Geriatr Soc; 2018 Jul; 66(7):1332-1338. PubMed ID: 29676433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
    Sarkar M; Hennessy S; Yang YX
    Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitors and Infant Pneumonia/Other Lower Respiratory Tract Infections: National Nested Case-control Study.
    Blank ML; Parkin L; Zeng J; Barson D
    J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):335-340. PubMed ID: 29601438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy and the risk for community-acquired pneumonia.
    Gau JT; Acharya U; Khan S; Heh V; Mody L; Kao TC
    BMC Geriatr; 2010 Jul; 10():45. PubMed ID: 20604960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia.
    de Groot MC; Klungel OH; Leufkens HG; van Dijk L; Grobbee DE; van de Garde EM
    Eur J Epidemiol; 2014 Oct; 29(10):767-75. PubMed ID: 25154551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis.
    Xun X; Yin Q; Fu Y; He X; Dong Z
    Ann Pharmacother; 2022 May; 56(5):524-532. PubMed ID: 34425689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.
    Meijvis SC; Cornips MC; Voorn GP; Souverein PC; Endeman H; Biesma DH; Leufkens HG; van de Garde EM
    Eur Respir J; 2011 Nov; 38(5):1165-72. PubMed ID: 21478217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.
    Suh DC; Hunsche E; Shin HC; Mavros P
    Rheumatology (Oxford); 2008 Apr; 47(4):458-63. PubMed ID: 18263598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
    Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
    Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
    Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.